Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705497 · ClinicalTrials.gov registry record · Phase 1
Radiofrequency Ablation of Tumors
A Phase 1 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT00705497 is a Phase 1 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 31 participants.
The verdict
NCT00705497, a Phase 1 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
Background: This prospective study was designed to be the first to evaluate the toxicity of radiofrequency ablation (RFA) in patients with recurrent pediatric solid tumors. Methods: From 2003 through 2006, we conducted a phase I, IRB-approved study of RFA for recurrent solid tumors. A multidisciplinary cancer management team selected appropriate candidates for the study. Imaging-guided RFA was performed percutaneously. Response was assessed at 3 months. Repeat RFA was performed for some incompletely ablated or new lesions.
Interventions
- PROCEDURE Radiofrequency Tumor Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705497
The ClinicalTrials.gov registry entry for NCT00705497 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency Tumor Ablation is the first listed.
NCT00705497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705497 about?
NCT00705497 is a clinical study titled "Radiofrequency Ablation of Tumors". Background: This prospective study was designed to be the first to evaluate the toxicity of radiofrequency ablation (RFA) in patients with recurrent pediatric solid tumors. Methods: From 2003 through 2006, we conducted a phase I, IRB-approved study of RFA for recurrent solid tumors. A multidiscipli...
What is the current status of trial NCT00705497?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2003-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00705497?
The interventions under investigation include: Radiofrequency Tumor Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00705497?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.